The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hepcludex (bulevirtide-gmod), in development by Gilead Sciences, for treating adults with…
FATTY LIVER DISEASE
Columns
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hepcludex (bulevirtide-gmod), in development by Gilead Sciences, for treating adults with…
CHOLESTASIS
NewsPeople with progressive familial intrahepatic cholestasis (PFIC), along with their families and clinicians, collaborated on a two-year project to develop a knowledge base for…
Discussion
ALAGILLE SYNDROME
ColumnsUntil this point in time, when it has come to raising my 5-year-old son, Finley, one of the things I’ve been focused on is managing…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.